OBN BioTuesday: A Spotlight on the latest research & innovation in the thriving FemTech market

The OBN team are pleased to announce details of our FemTech focused BioTuesday event, kindly hosted by FTI in London on Tuesday 6 February.


The evening has been designed to spotlight the latest research & innovation in the thriving FemTech market, which over the course of just a few years, has grown to encompass a range of technology-enabled, consumer-centric products and solutions.


FemTech companies are disrupting healthcare in a number of ways, with impactful companies being developed across a range of areas, including:

  • Improving care delivery via virtual clinics and direct to consumer services
  • Enabling self-care via the development of trackers and wearables, at-home diagnostics and solutions that are helping women take greater charge of their health and health-related data.
  • Improved diagnostics that are pushing the scientific frontier to address unmet medical needs
  • Addressing stigmatized areas such as menstrual health, sexual health, pelvic care and menopause 


Speakers on the night will share an update on the latest innovation and funding in the space, and projections for future growth and patient impact. 


Programme:

18.00 – 18.30 Guest arrivals and networking

18.30 – 19.00 Welcome & Keynote Presentations

19.00 - 20.00 R&D Showcase Presentations featuring exciting FemTech focused R&D companies

20.00 - 20.30 Audience & Presenter Q&A

20.30 – 21.30 Networking


About FTI Consulting

Over the last 40 years, FTI Consulting has grown to become a market-leading global consulting firm that brings together distinct capabilities and experts to serve as the trusted advisor to clients when they are facing their greatest opportunities and challenges. Each practice is a leader in its own right, staffed with experts recognized for the depth of their knowledge and a track record of making an impact. Collectively, FTI Consulting offers a comprehensive suite of services designed to assist clients across the business cycle—from proactive risk management to the ability to respond rapidly to unexpected crises and dynamic environments.

Speakers

  • Angela Hobbs (Founder and CEO of Wilkinson Hall)

    Angela Hobbs

    Founder and CEO of Wilkinson Hall

    view more
  • Peony Li (Founder and CEO of Jude)

    Peony Li

    Founder and CEO of Jude

    view more
  • Rob Milnes (CEO of viO HealthTech)

    Rob Milnes

    CEO of viO HealthTech

    https://www.viohealthtech.com/

    Rob has over 30 years experience in financing and bringing ground-breaking medical technology and software to global markets, with the past 20 years focussed on women’s health. Co-inventor of 6 OvuSense patents and co-author of several clinical publications, he is also CEO of viO HealthTech Inc., the company’s wholly owned US subsidiary. Rob has worked for Roche, Oxford Instruments, and was formerly a member of the Operations Board of Huntleigh Healthcare following the successful sale and integration of the Sonicaid Fetal Monitoring and Medilog Cardiology businesses. He brings extensive experience in international sales & marketing, M&A, sub-contract manufacturing, finance and systems.

    view more

Venue

FTI Consulting

200 Aldersgate
Aldersgate Street
London
EC1A 4HD

United Kingdom

If you have any questions please contact Isabel Coleman

Contact Organizer

Show on map

Tickets

OBN Member Ticket
Member Price Complimentary
Non-Member Ticket
Standard Price £50